miRNAs as serum biomarkers for Duchenne muscular dystrophy D Cacchiarelli, I Legnini, J Martone, V Cazzella, A d'Amico, E Bertini, ... EMBO molecular medicine 3 (5), 258-265, 2011 | 293 | 2011 |
MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway D Cacchiarelli, J Martone, E Girardi, M Cesana, T Incitti, M Morlando, ... Cell metabolism 12 (4), 341-351, 2010 | 279 | 2010 |
The Dof protein DAG1 mediates PIL5 activity on seed germination by negatively regulating GA biosynthetic gene AtGA3ox1 S Gabriele, A Rizza, J Martone, P Circelli, P Costantino, P Vittorioso The Plant Journal 61 (2), 312-323, 2010 | 194 | 2010 |
miR‐31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy D Cacchiarelli, T Incitti, J Martone, M Cesana, V Cazzella, T Santini, ... EMBO reports 12 (2), 136-141, 2011 | 170 | 2011 |
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients G Dobrowolny, J Martone, E Lepore, I Casola, A Petrucci, M Inghilleri, ... Cell death discovery 7 (1), 4, 2021 | 63 | 2021 |
The long non-coding RNA lnc-31 interacts with Rock1 mRNA and mediates its YB-1-dependent translation D Dimartino, A Colantoni, M Ballarino, J Martone, D Mariani, J Danner, ... Cell reports 23 (3), 733-740, 2018 | 62 | 2018 |
Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts V Cazzella, J Martone, C Pinnarò, T Santini, SS Twayana, O Sthandier, ... Molecular Therapy 20 (11), 2134-2142, 2012 | 60 | 2012 |
miRNA BIOMARKERS FOR THE DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHY, ITS PROGRESSION AND FOR MONITORING THERAPEUTIC INTERVENTIONS I Bozzoni, J Martone, D Cacchiarelli, E Girardi US Patent App. 13/322,026, 2012 | 39 | 2012 |
Non-coding RNAs shaping muscle J Martone, D Mariani, F Desideri, M Ballarino Frontiers in cell and developmental biology 7, 394, 2020 | 38 | 2020 |
Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia F Spallotta, S Tardivo, S Nanni, JD Rosati, S Straino, A Mai, M Vecellio, ... Journal of Biological Chemistry 288 (32), 22915-22929, 2013 | 34 | 2013 |
SMaRT lncRNA controls translation of a G‐quadruplex‐containing mRNA antagonizing the DHX36 helicase J Martone, D Mariani, T Santini, A Setti, S Shamloo, A Colantoni, ... EMBO reports 21 (6), e49942, 2020 | 29 | 2020 |
The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype J Martone, F Briganti, I Legnini, M Morlando, E Picillo, O Sthandier, ... Nature Communications 7 (1), 10488, 2016 | 26 | 2016 |
Visualization of nuclear and cytoplasmic long noncoding RNAs at single-cell level by RNA-FISH T Santini, J Martone, M Ballarino Capturing Chromosome Conformation: Methods and Protocols, 251-280, 2021 | 12 | 2021 |
U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction J Martone, FG De Angelis, I Bozzoni Exon Skipping: Methods and Protocols, 239-257, 2012 | 12 | 2012 |
Trans‐generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy J Martone, M Lisi, F Castagnetti, A Rosa, V Di Carlo, E Blanco, A Setti, ... EMBO Molecular Medicine 12 (8), e12063, 2020 | 8 | 2020 |
Lnc-SMaRT translational regulation of Spire1, a new player in muscle differentiation S Scalzitti, D Mariani, A Setti, A Colantoni, M Lisi, I Bozzoni, J Martone Journal of Molecular Biology 434 (2), 167384, 2022 | 4 | 2022 |
miR-31 in duchenne muscular dystrophy therapy I Bozzoni, J Martone, D Cacchiarelli, T Incitti US Patent 9,034,838, 2015 | 2 | 2015 |
A KO mouse model for the lncRNA Lhx1os produces motor neuron alterations and locomotor impairment F Pellegrini, V Padovano, S Biscarini, T Santini, A Setti, SG Galfrè, ... iScience 26 (1), 2023 | 1 | 2023 |
miRNAs as serum biomarkers for Duchenne muscular dystrophy: Correlation analysis in a multicentre study between miRNA levels and clinical status of DMD patients A D'Amico, J Martone, S Previtali, G Baranello, G D'Angelo, A Berardinelli, ... Neuromuscular Disorders 25, S252, 2015 | | 2015 |
DI 2 Role of miRNA in muscle differentiation and in Duchenne Muscular Dystrophy I Bozzoni, D Cacchiareli, J Martone, M Cesana, V Cazzella, C Pinnarò, ... Neuromuscular Disorders 21 (9), 639, 2011 | | 2011 |